Mary-Claire King

Title: Mary-Claire King: Pioneering Innovator in Genetic Research

Introduction

Mary-Claire King is a renowned inventor and researcher based in Seattle, WA. She has made significant contributions to the field of genetics, particularly in the understanding and treatment of cancer. With a total of 5 patents to her name, her work has had a profound impact on both scientific research and clinical applications.

Latest Patents

Among her latest patents, King has developed modulators of actin, which provide methods and compositions for modulating the stabilization of actin filaments. These compositions may include polypeptide moieties derived from a novel human diaphanous polypeptide and nucleic acid moieties from a novel human diaphanous gene. Additionally, she has created therapeutic methods for prostate cancer, utilizing gene therapy methods that involve the BRCA family of genes, including BRCA1 and BRCA2. These gene products are known to inhibit the growth and tumorigenesis of prostate cancer cells.

Career Highlights

Mary-Claire King has held prominent positions at esteemed institutions such as the University of Washington and Vanderbilt University. Her research has not only advanced scientific knowledge but has also paved the way for innovative therapeutic approaches in oncology.

Collaborations

Throughout her career, King has collaborated with notable colleagues, including Jeffrey T. Holt and Roy A. Jensen. These partnerships have further enriched her research and contributed to the advancement of genetic studies.

Conclusion

Mary-Claire King's contributions to genetic research and her innovative patents have established her as a leading figure in the field. Her work continues to inspire future generations of scientists and inventors.